| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant's Biz Strategy | ||
| Fr | The Silent Epidemic: Why Diabetic Foot Ulcers Have Been Overlooked for Three Decades | ||
| Fr | Reading the Body's Signals: AI's Ultimate Healthcare Opportunity | ||
| Do | AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New Indication | ||
| Do | Datavant's New Platform Could Cut Record Retrieval Time from Days to Hours | ||
| Do | Precision Medicine Transformed Oncology -It's Time to Do the Same for Sepsis | ||
| Do | What Do the Latest Iteration of Consumer Drug Platforms Offer? | ||
| Mi | Onos Health Raises $17M to Expand AI-Powered Behavioral Health Platform | ||
| Mi | Cyberattack Disrupts Boston Scientific's Operations: 7 Things to Know | ||
| Mi | Revolution Medicines Receives Landmark FDA Drug Approval in Pancreatic Cancer | ||
| Mi | Stop Pitching the Institute - Pitch the Stack | ||
| Mi | Why Oura's Sleep-Tracking Lawsuit Is Really About Trust | ||
| Mi | Business Group on Health: Employer Healthcare Costs Projected to Rise 9.2% in 2027 | ||
| Di | J&J's Imaavy Becomes First FDA-Approved Therapy for Rare Form of Anemia | ||
| Di | Before You Sign That AI Contract: 7 Questions Every Healthcare CFO Should Ask | ||
| Di | 4 Patients Injured After Drug Mix-Up at Ascension Hospital in Nashville | ||
| Mo | Amazon Taps Expressable for Health Benefits Connector | ||
| Mo | Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle | ||
| Mo | A Partnership-driven Approach to Waste and Abuse Prevention | ||
| Mo | Why Psychiatry Can't Ignore Metabolic Health Anymore | ||
| So | Ambient Scribes Improve Clinician Retention, Cleveland Clinic Research Shows | ||
| So | Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs | ||
| So | Cityblock to Acquire Homeward Health, Secures $116M Series E | ||
| So | How to Prepare Your Hospital Before H.R. 1 Hits in 2027 | ||
| 21.08. | Ambros Therapeutics' Path for Pain Drug Goes Through Reverse Merger With Werewolf Therapeutics |